OncLive | First-Line Standard for Metastatic RCC Upheld OncLive Robert J. Motzer, MD. The standard of care for metastatic renal cell carcinoma (RCC) prevailed in a randomized comparison of everolimus (Afinitor) and sunitinib (Sutent) as first-line therapy, according to data presented at the 2013 ASCO Annual Meeting. |
